CareDx (CDNA) expects full year 2025 adjusted EBITDA gain to be in the range of $29M-$33M.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CDNA:
- CareDx reports District Court reverses jury decision in patent infringement case
- CDNA Earnings Report this Week: Is It a Buy, Ahead of Earnings?
- CareDx announces AlloSeq cfDNA study data published in Transplant International
- Wells Fargo upgrades CareDx to Equal Weight on improved risk/reward
- CareDx upgraded to Equal Weight from Underweight at Wells Fargo